ASX Penny Stocks To Watch In January 2025

In This Article:

The Australian market recently saw the ASX200 reach a record high, buoyed by positive investor sentiment and strong performances in sectors like IT, Materials, and Real Estate. Penny stocks, while often overlooked due to their smaller size or newer status, can still offer compelling opportunities for growth when backed by solid financials. As investors seek out hidden gems with potential for long-term success, these stocks present an intriguing option worth considering amidst the current market dynamics.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.78

A$143.12M

★★★★☆☆

LaserBond (ASX:LBL)

A$0.57

A$66.82M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.50

A$310.07M

★★★★★☆

MaxiPARTS (ASX:MXI)

A$1.92

A$106.21M

★★★★★★

GTN (ASX:GTN)

A$0.55

A$108.01M

★★★★★★

Helloworld Travel (ASX:HLO)

A$2.01

A$327.26M

★★★★★★

SHAPE Australia (ASX:SHA)

A$2.96

A$245.42M

★★★★★★

IVE Group (ASX:IGL)

A$2.23

A$345.4M

★★★★☆☆

Vita Life Sciences (ASX:VLS)

A$1.88

A$104.6M

★★★★★★

SKS Technologies Group (ASX:SKS)

A$1.59

A$247.67M

★★★★★★

Click here to see the full list of 1,028 stocks from our ASX Penny Stocks screener.

Let's take a closer look at a couple of our picks from the screened companies.

Jupiter Mines

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Jupiter Mines Limited is an independent mining company based in Australia with a market capitalization of A$303.96 million.

Operations: The company generates revenue from its manganese operations in South Africa, amounting to A$8.07 million.

Market Cap: A$303.96M

Jupiter Mines Limited, with a market cap of A$303.96 million, faces challenges typical of penny stocks, including negative earnings growth and declining profits over the past five years. Despite trading at 23.8% below its estimated fair value and being debt-free with sufficient short-term assets to cover liabilities, its dividend yield of 8.06% is not well supported by free cash flow. The company's return on equity is low at 7.2%, and it has experienced lower profit margins compared to last year. Additionally, the board's average tenure suggests limited experience which could impact strategic decisions.

ASX:JMS Financial Position Analysis as at Jan 2025
ASX:JMS Financial Position Analysis as at Jan 2025

Mach7 Technologies

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Mach7 Technologies Limited offers enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises globally, with a market cap of A$98.91 million.